Aspirin and simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes

Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events

Amlodipine Versus Angiotensin II receptor blocker: Control of blood pressure Evaluation trial in Diabetics – Japan

Albumin in Acute Stroke

Assessment of Lipophilic vs hydrophilic Statin therapy in Acute Myocardial Infarction

Angiotensin II antagonist In Paroxysmal Atrial Fibrillation

Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure

Aortic Stenosis progression Observation: Measuring Effects of Rosuvastatin

Cortisone plus BMS or DES versus BMS alone to eliminate restenosis

China Intensive Lipid Lowering with statins in Acute coronary Syndrome

Chinese Medicine Neuroaid^® Efficacy on Stroke recovery

Comparison of Intracoronary versus intravenous abciximab administration during Emergency Reperfusion Of ST-segment elevation myocardial infarction

Copenhagen Insulin and Metformin Therapy

Clopidogrel to Improve Primary percutaneous coronary intervention in Acute Myocardial Infarction

Diabetic Atherosclerosis Prevention by Cilostazol

Efficacy of Nitric Oxide in Stroke

Exogenous erythropoietin in Acute Myocardial Infarction: New Outlook and Dose Association Study

Efficacy of Xience/promus versus Cypher in reducing Late Loss after stenting

Extended Clinical prophylaxis in Acutely Ill Medical patients

Omega-3 fatty acids (Fish oils) and Aspirin in Vascular access Outcomes in Renal Disease

Fosinopril in Dialysis

Follow-Up Serial Infusions Of Nesiritide II

Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocradico – Atrial Fibrillation

Gauging Responsiveness with A VerifyNow assay – Impact on Thrombosis And Safety

Hypertension Objective treatment based on Measurement by Electrical Devices of BP

Investigation on Colchicine for Acute Pericarditis

Irbesartan in the Management of Proteinuric patients at high risk for Vascular Events

Improved Reduction of Outcomes: Vytorin Efficacy International Trial

Incipient to Overt: Angiotensin II receptor blocker, Telmisartan, Investigation On type 2 diabetic Nephropathy

Intracoronary Stenting and Antithrombotic Regimen: Safety And efficacy of six months dual antiplatelet therapy after drug-Eluting stenting

Effect of losartan and amlodipine on left ventricular diastolic function in patients with mild-to-moderate hypertension

Korean Health and Genome Study

Action for Health in Diabetes

Medical Antiarrhythmic Treatment or Radiofrequency Ablation in Paroxysmal Atrial Fibrillation

Melatonin Adjunct in the acute myocardial Infarction treated with Angioplasty

Myocardial Infarction Secondary Prevention Study

Media Intima Thickness Evaluation of Candesartan

Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research

Olmesartan Clinical Trial in Okinawan Patients Under OKIDS

Ongoing Tirofiban In Myocardial infarction Evaluation 2

Olmesartan and Calcium Antagonists Randomized study

Prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack

Platelet Responsiveness to Aspirin and Clopidogrel and Troponin Increment after Coronary intervention in Acute coronary Lesions

Pakistan Risk Of Myocardial Infarction Study

Patient Related Outcomes with Endeavor versus Cypher stenting Trial

Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of glycaemia in Diabetes

Renin-Aldosterone

Randomised Olmesartan And Diabetes Microalbuminuria Prevention

Stop Atherosclerosis in Native Diabetics Study

Transplantation In Myocardial infarction Evaluation

Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure

Thrombin Receptor Antagonist in Secondary Prevention – Thrombolysis In Myocardial Infarction 50

Thrombin Receptor Antagonist for Clinical Event Reduction

Treatment with statin on atheroma Regression evaluated by intravascular Ultrasound with virtual Histology

Valsartan Cardio-Renal Protection

Valsartan In Diastolic Dysfunction

Vein-Coronary atherosclerosis and Rosiglitazone after bypass surgery

What is the Optimal antiplatelet and anticoagulant therapy in patients with oral anticoagulation and coronary Stenting